Skip to main content

Table 1 Characteristics (i.e., sex and diagnosis) of the study population according to age group (≥ 65 vs. < 65 years)

From: Psychotropic drug-induced adverse drug reactions in 462,661 psychiatric inpatients in relation to age: results from a German drug surveillance program from 1993–2016

 

Patients ≥ 65 years (% of patients ≥ 65 years)

Patients < 65 years (% of patients < 65 years)

Chi2-Test (χ2, df, p)

Post-hoc Chi22, df, p)

Total

99,099 (100%)

363,562 (100%)

  

Sex

 Females

67,655 (68.3%)

190,935 (52.5%)

χ2 = 7837.955; df = 1; p < 0.001

 

 Males

31,444 (31.7%)

172,627 (47.5%)

 

Diagnosis (ICD-10)

 Organic disorders (F0)a

32,677 (33.0%)

23,742 (6.5%)

χ2 = 64,910.712; df = 5; p < 0.001

χ2 = 50,856.358; df = 1; p < 0.001

 Substance-related disorders (F1)

2217 (2.2%)

18,420 (5.1%)

χ2 = 1462.853; df = 1; p < 0.001

 Schizophrenia (F2)

15,940 (16.1%)

142,097 (39.1%)

χ2 = 18,316.130; df = 1; p < 0.001

 Depressive disorders (F3 without F30, F31.0–F31.2)

40,685 (41.1%)

117,313 (32.3%)

χ2 = 2673.889; df = 1; p < 0.001

 Acute mania (F30, F31.0–F31.2)

2344 (2.4%)

10,823 (3.0%)

χ2 = 105.358; df = 1; p < 0.001

 Others (F4–F9)

5236 (5.3%)

51,167 (14.1%)

χ2 = 5620.874; df = 1; p < 0.001

  1. df degrees of freedom; ICD-10 International Classification of Disease, 10th Version
  2. aIncluding organic disorders from F1 and F7